Carl Dockery - Net Worth and Insider Trading
Carl Dockery Net Worth
The estimated net worth of Carl Dockery is at least $279,568 dollars as of 2024-11-13. Carl Dockery is the Director, 10% Owner of CytoDyn Inc and owns about 2,236,543 shares of CytoDyn Inc (CYDY) stock worth over $279,568. Details can be seen in Carl Dockery's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carl Dockery has not made any transactions after 2015-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carl Dockery
Carl Dockery Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl Dockery owns 3 companies in total, including Aytu BioPharma Inc (AYTU) , CytoDyn Inc (CYDY) , and Rezolute Inc (RZLT) .
Click here to see the complete history of Carl Dockery’s form 4 insider trades.
Insider Ownership Summary of Carl Dockery
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AYTU | Aytu BioPharma Inc | 2023-08-11 | director |
| CYDY | CytoDyn Inc | 2015-06-05 | director & 10 percent owner |
| RZLT | Rezolute Inc | 2014-04-01 | other: See remarks |
Carl Dockery Latest Holdings Summary
Carl Dockery currently owns a total of 1 stock. Carl Dockery owns 2,236,543 shares of CytoDyn Inc (CYDY) as of June 5, 2015, with a value of $279,568.
Latest Holdings of Carl Dockery
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYDY | CytoDyn Inc | 2015-06-05 | 2,236,543 | 0.13 | 279,568 |
Holding Weightings of Carl Dockery
Carl Dockery Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl Dockery has made a total of 0 transactions in CytoDyn Inc (CYDY) over the past 5 years. The most-recent trade in CytoDyn Inc is the acquisition of 140,843 shares on June 5, 2015, which cost Carl Dockery around $70,422.
Insider Trading History of Carl Dockery
- 1
Carl Dockery Trading Performance
GuruFocus tracks the stock performance after each of Carl Dockery's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carl Dockery is -17.39%. GuruFocus also compares Carl Dockery's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carl Dockery within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carl Dockery's insider trading performs compared to the benchmark.
Performance of Carl Dockery
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.52 | | | | | |
| Relative Return to S&P 500(%) | -5.75 | | | | | |
Carl Dockery Ownership Network
Ownership Network List of Carl Dockery
Ownership Network Relation of Carl Dockery
Carl Dockery Owned Company Details
What does Aytu BioPharma Inc do?
Who are the key executives at Aytu BioPharma Inc?
Carl Dockery is the director of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Financial Officer Mark K Oki , Chief Operating Officer Christopher Brooke , and Chief Business Officer Jarrett Disbrow .
Aytu BioPharma Inc (AYTU) Insider Trades Summary
Over the past 18 months, Carl Dockery made no insider transaction in Aytu BioPharma Inc (AYTU). Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 14,000 shares made by Joshua R. Disbrow ,
In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 14,000 shares were bought by its insiders, resulting in a net purchase of 14,000 shares.
Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aytu BioPharma Inc Insider Transactions
Carl Dockery Mailing Address
Above is the net worth, insider trading, and ownership report for Carl Dockery. You might contact Carl Dockery via mailing address: P.o. Box 2477, Lakeland Fl 33806-2477.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
